87
72
Growth Score 87 in past quarter
83 pts
Heat Score 72 in past quarter
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
490360
HEMEO IS A PERSONALIZED CLINICAL DECISION SUPPORT SYSTEM DESIGNED TO PREVENT, DIAGNOSE, AND TREAT COAGULATION DISORDERS
- Remi Corlin: CEOPast Role: Haemonetics, Vice President International Markets
About the Company
Hemeo’s core technology is a computational model of the blood coagulation system that has been perfected using the laboratory data from thousands of persons. When now fed with a single patient’s laboratory data, the model can make personalized thrombosis and bleeding risk estimations and hence personalized treatment recommendations.